Cost of revenue · 2011–2025
Sinovac Biotech cost of revenue
$124M−11.8% · FY2025
Sinovac Biotech (SVA) reported $124M in cost of revenue for fiscal 2025, −11.8% year on year.
| Fiscal year | Cost of revenue | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $124M | −11.8% | Open → |
| FY20242024-12-31 | $141M | −4.2% | Open → |
| FY20232023-12-31 | $147M | −77.7% | Open → |
| FY20222022-12-31 | $658M | −33.4% | Open → |
| FY20212021-12-31 | $989M | +1,372.0% | Open → |
| FY20202020-12-31 | $67.2M | +106.9% | Open → |
| FY20192019-12-31 | $32.5M | +31.3% | Open → |
| FY20182018-12-31 | $24.7M | +22.1% | Open → |
| FY20172017-12-31 | $20.2M | −9.6% | Open → |
| FY20162016-12-31 | $22.4M | +21.6% | Open → |
| FY20152015-12-31 | $18.4M | +18.9% | Open → |
| FY20142014-12-31 | $15.5M | −24.5% | Open → |
| FY20132013-12-31 | $20.5M | +7.4% | Open → |
| FY20122012-12-31 | $19.1M | −9.6% | Open → |
| FY20112011-12-31 | $21.1M | — | Open → |
Cost of revenue — Cost of revenue is the direct cost of producing what the company sold — materials, manufacturing and the labour tied to delivery. It excludes sales, marketing and administration. Revenue minus this figure is gross profit.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +13.5%
Cost of revenue at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Sinovac Biotech cost of revenue |url=https://companiesranked.com/en/company/sinovac-biotech/cost-of-revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Sinovac Biotech cost of revenue. CompaniesRanked. https://companiesranked.com/en/company/sinovac-biotech/cost-of-revenueBibTeX
@misc{companiesranked-en-company-sinovac-biotech-cost-of-revenue-2026,
author = {{CompaniesRanked}},
title = {{Sinovac Biotech cost of revenue}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/sinovac-biotech/cost-of-revenue}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001193125-26-258534 · June 5, 2026
{{cite web |title=Sinovac Biotech cost of revenue — 20-F (0001193125-26-258534) |url=https://www.sec.gov/Archives/edgar/data/1084201/000119312526258534/sva-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-06-05}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.